1 not yet recruiting, 1 recruiting, 1 unknown. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow ENCell: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia EN001, EN001 Placebo - Sarcopenia | Phase 1 / Phase 2 | Not yet recruiting | ENCell | 132 | 2027-03-01 | 2026-09-11 |
| Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A(CMT1A) (Phase 1b: Open-label, Dose-escalation, Single-center; Phase 2a: Randomized, Double-blind, Placebo-controlled, Multicenter) EN001, EN001 Placebo - Charcot-Marie-Tooth Disease Type 1A | Phase 1 / Phase 2 | Recruiting | ENCell | 27 | 2024-05-30 | 2026-05-26 |
| Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy EN001 - Duchenne Muscular Dystrophy | Phase 1 / Phase 2 | Unknown | ENCell | 88 | 2024-03-01 | 2024-03-25 |
Charcot-Marie-Tooth Disease (1) · Muscular Dystrophy, Duchenne (1) · Sarcopenia (1)
South Korea (3)